openPR Logo
Press release

Cancer Biomarkers Market to reach US$ 29.3 Billion by 2023 End

08-13-2018 11:01 AM CET | Health & Medicine

Press release from: Genesis market insights

Cancer Biomarkers Market

Cancer Biomarkers Market

GLOBAL CANCER BIOMARKERS MARKET was valued at USD 13.49 Billion in the year 2017. Global Cancer Biomarkers market is further estimated to grow at a CAGR of 13.8% from 2018 to reach USD 29.3 Billion by the year 2023.

Get Free Access to Sample Report @

The Global Cancer Biomarkers is segmented as by cancer type, by profiling technology, by biomarkers, and by region. On the basis of the type of cancer the market is segmented as Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer and Others of which breast cancer holds the highest market share.

On the basis of Profiling Technology, the Global Cancer Biomarkers market is segmented as OMICS Technology, Imaging Technology, Immunoassays, Cytogenetics, and Bioinformatics of which OMICS Technology is expected to hold the highest market share in the forecasted period.

On the other hand, by a Biomarkers Type, the market is segmented as Protein Biomarkers, Genetic Biomarkers and Others for this protein biomarker segment are expected to grow at highest CAGR during the year 2018-2023. The large share of this segment is mainly attributed to the tremendous potential of protein biomarkers in cancer detection.

Asia Pacific region holds the highest market share in 2017 and North America is considered as the fastest growing market in the forecasted period. At a country level, Japan, China, and South Korea are projected to grow strongly in the coming years. Factors such as rising incidence of cancer, increasing use of biomarker tests for diagnostic purposes and government support to research institutes and universities are further driving the growth of this market in the APAC region.


• Increased Incidences of Cancer Globally
• Higher Acceptance for Treatment in Developing Regions


• High Cost of Diagnosis and Reimbursement Issues


• Technological and Scientific advancements
• Emerging Economies


• Unfavorable Regulatory framework and policies

23andMe (U.S), Agilent Technologies (U.S), Abbott Laboratories, Inc. (U.S), Biomerieux (France), Hologic, Inc. (U.S),Roche Holding AG (Switzerland), Illumina, Inc. (U.S), Roche Diagnostics (Switzerland), GE Healthcare (U.S) and Bio-Rad Laboratories (U.S)are some of the key players in the Cancer Biomarkers Market. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

Key Benefits for Stakeholders

• Manufacturing companies of diagnostics kits and imaging instrument providers
• Contract research organizations (CROs)
• Healthcare organizations and R&D Institutes
• Various Research organizations and consulting firms
• The government, Regulatory bodies, and consumers

By Cancer Type

• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

By Profiling Technology

• OMICS Technology
• Imaging Technology
• Immunoassays
• Cytogenetics
• Bioinformatics

By Biomarkers Type

• Protein Biomarkers
• Genetic Biomarkers
• Others

By Region

• North America
• Europe
• Asia-Pacific
• RoW

Key Market Players

• 23andMe
• Agilent Technologies
• Abbott Laboratories, Inc.
• Biomerieux
• Hologic, Inc.
• Roche Holding AG
• Illumina, Inc.
• Roche Diagnostics
• GE Healthcare
• Bio-Rad Laboratories
• (Another brief information of 10 companies will be provided in the report)

Read Report Overview with Full TOC @

About Us:

Genesis Market Insights (GMI), is a subsidiary of Genesis Management & Market Research Pvt.Ltd. (GMMR) having a strong experience both in primary and secondary market research serving small to large scale enterprises across globe. Established in 1993, GMMR has become a recommended brand for Market Research for various international and MNC Corporations with its strong data foundation. With its exhaustive research capabilities, strong analytics services and in house data validation tools, GMMR has delivered actionable, reliable and all-inclusive Market Research Reports. GMMR is growing strongly for last 2 decades with most of the clients providing repeat business for their trust on the data quality and recommendations for decision making.

Contact Us;

Genesis Market Insights (GMI)
902 Broadway, 6th Floor,
New York, NY 10010
(212) 634-4560
Mail us at:

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Biomarkers Market to reach US$ 29.3 Billion by 2023 End here

News-ID: 1175917 • Views: 805

More Releases from Genesis market insights

Solar Panel Recycling Industry By Product Polycrystalline, Monocrystalline, Thin …
Solar panel regeneration market was estimated at $ 77.95 million in 2018. The global solar panel recycling market is expected to grow to a CAGR of 27.04% by 2019, reaching $ 327.69 million by 2025. Europe has the highest market The Asia Pacific market is considered the fastest-growing market during the forecast period. By country, Germany has the largest market share in 2017 and is expected to grow strongly over
Advance Marijuana Industry Report by Top Manufacturers, Countries, Type and Appl …
Advance Marijuana Market was valued at USD 17.18 Billion in the year 2017. Global Marijuana Market is further estimated to grow at a CAGR of 22.91% from 2018 to reach USD 58.90 Billion by the year 2023. North America region holds the highest market share in 2017 and also considered as the fastest growing market in the forecasted period. At a country level, developed markets like the U.S., Canada holds
In-vitro fertilization (IVF) Market Types of cycle, Thawed IVF, Application, Siz …
IVF is the most effective form of assisted reproductive technology. Procedures can be performed using your own eggs and your partner's sperm. Or IVF may include egg, sperm or embryo of a known or anonymous donor. In some cases, a pregnant carrier with a fetus implanted in the uterus may be used. The likelihood of having a healthy baby using IVF depends on many factors, including age and the cause of
Advance IOT Sensors Market Expected to Reach US $+25 billion by 2023 Top Market …
IoT sensors in the automotive industry and the booming industry IoT market are driving the growth of the IoT sensor market. In addition, market growth is accelerating as demand for home appliances such as smart devices (smart TVs, smart phones, etc.) increases. The growth of the global IoT sensor market is accelerating with the increase in sales of consumer electronics products. Smart electric and water meters are also expected to

All 5 Releases

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top